Cipla on the block: Who's a better fit and what it means for shareholders?

India’s third-largest pharmaceutical company by revenue, Cipla, is up for grabs in a three-way fight between Torrent Pharmaceuticals, Dr Reddy’s Laboratories (DRL) and private equity......

US drug shortage, stable pricing set to boost pharma revenues

An acute drug shortage in the US and stable pricing along with product launches are likely to boost revenues of India’s pharmaceutical companies during the first quarter of this financial......

India Inc braces for fallout of Russia-Ukraine crisis

Stocks of Indian companies with exposure to Europe fell on Tuesday amid concerns about the impact on their sales in case the Russia-Ukraine crisis worsens and the US and its allies impose economic......

Mercedes-Benz S-Class gets a facelift

The new Mercedes-Benz S-Class has undergone some cosmetic changes, but it's under the hood where a massive overhaul has taken place. Essentially a mid-life facelift, the new Mercedes-Benz S-Class......